Extraordinary clinical benefit to sequential treatment with targeted therapy and immunotherapy of a BRAF V600E and PD-L1 positive metastatic lung adenocarcinoma

Overview of attention for article published in Experimental Hematology & Oncology, November 2017

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

So far, Dimensions has found 11 publications that cite this research output.

Article in Cancers (October 2022)

Article in Frontiers in Oncology (July 2022)

Article in Translational Lung Cancer Research (December 2019)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.